Home

Akebia Therapeutics, Inc. - Common Stock (AKBA)

2.0400
-0.8000 (-28.17%)

Akebia Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with kidney disease

The company is primarily engaged in addressing unmet medical needs in anemia caused by chronic kidney disease, aiming to enhance patient outcomes through its proprietary treatments and drug candidates. Akebia's research and development efforts are centered around creating therapies that improve the management of renal diseases by promoting better health and quality of life for patients suffering from kidney-related conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ
Here are the top movers in Thursday's session.chartmill.com
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · March 20, 2025
Top movers in Thursday's sessionchartmill.com
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 20, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · March 20, 2025
Which stocks are gapping on Thursday?chartmill.com
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · March 20, 2025
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increasebenzinga.com
Via Benzinga · March 20, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 20, 2025
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 20, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 20, 2025
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 20, 2025
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · March 19, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · March 19, 2025
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 18, 2025
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 14, 2025
Which stocks are experiencing notable movement on Friday?chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · March 14, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 14, 2025
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · March 14, 2025
Earnings Scheduled For March 13, 2025benzinga.com
Via Benzinga · March 13, 2025
AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com
AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 10, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 29, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · March 28, 2024
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemiabenzinga.com
The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disease. Learn about its once-daily oral HIF-PH inhibitor and global approval in 37 countries.
Via Benzinga · March 28, 2024
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
Via Benzinga · March 28, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 28, 2024
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via Benzinga · March 27, 2024